8 unknown. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Unknown 8 |
Follow Hyperglycemia: new trials by email Literature Review of Hyperglycemia trials Research Report on Hyperglycemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. Berberine, Placebo - Metabolic Syndrome, HIV-1-infection | Phase 3 | Unknown | Hospital Civil de Guadalajara | 40 | 2021-04-01 | 2021-04-26 |
| Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke Insulin Glargine, Regular Insulin - Acute Stroke, Hyperglycemia | Phase 3 | Unknown | National Taiwan University Hospital | 120 | 2015-12-01 | 2016-08-19 |
| L-arginine and Brown Adipose Tissue L-arginine, Placebo - Adipose Tissue, Brown, Glucose Intolerance | Phase 3 | Unknown | Maastricht University Medical Center | 26 | 2014-11-01 | 2014-11-14 |
| Nutritional Requirement for the Severe Trauma Patients high caloric nutritional supplement, low caloric nutritional supplement - Trauma | Phase 3 | Unknown | Asan Medical Center | 61 | 2012-11-01 | 2013-01-04 |
| Probiotics (Lactobacillus Rhamnosus) in Reducing Glucose Intolerance During and After Pregnancy Probiotics Lactobacillus Rhamnosus - Glucose Intolerance, Pregnancy | Phase 3 | Unknown | Aga Khan University | 200 | 2011-10-01 | 2011-09-20 |
| Impact of 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted in ICU Strict glycemic control, Conventional glycemic control - Hyperglycemia, Critically Ill Patients | Phase 3 | Unknown | Poissy-Saint Germain Hospital | 440 | 2008-01-01 | 2008-02-14 |
| Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay Insulin - Cystic Fibrosis, Glucose Intolerance | Phase 3 | Unknown | Fondazione per la ricerca sulla Fibrosi Cistica | 70 | 2005-08-01 | 2009-08-04 |
| Prevention of Corticosteroid-induced Glucose Intolerance Rosiglitazone - Glucose Intolerance | Phase 3 | Unknown | Hadassah Medical Organization | 100 | 2005-04-01 | 2011-09-14 |
Glucose Intolerance (5) · Cystic Fibrosis (1) · Dyslipidemias (1) · Hypoglycemia (1) · Insulin Resistance (1) · Lipodystrophy (1) · Metabolic Syndrome (1) · Patient Compliance (1) · Stroke (1) · Wounds and Injuries (1)
Glucose Metabolism Disorders (8) · Metabolic Diseases (8) · Nutritional and Metabolic Diseases (8) · Hyperinsulinism (2) · Behavior (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Genetic Diseases, Inborn (1) · Health Behavior (1) · Infant, Newborn, Diseases (1)
Insulin (2) · Insulin Glargine (2) · Arginine (1) · Berberine (1) · Rosiglitazone (1)
Aga Khan University (1) · Asan Medical Center (1) · Fondazione per la ricerca sulla Fibrosi Cistica (1) · Hadassah Medical Organization (1) · Hospital Civil de Guadalajara (1) · Maastricht University Medical Center (1) · National Taiwan University Hospital (1) · Poissy-Saint Germain Hospital (1)
France (1) · Israel (1) · Italy (1) · Netherlands (1) · Pakistan (1) · South Korea (1) · Taiwan (1)
Abdul Jabbar, MBBS, FRCP (1) · Ali Khowaja, FRCS (1) · Arie BenYehuda, MD (1) · Bilal Ahmed, MSc (1) · Jean-Claude Lacherade, MD (1) · Jiann-Shing Jeng, MD. PhD (1) · Kashmira Nanji, MSc (1) · Laura Minicucci, MD (1) · Rozina Sikandar, MBBS, FCPS (1) · Sarah Saleem, MBBS, MSc (1) · Suk-Kyung Hong, MD, PhD. (1)
PMID 30070030, PMID 30377712, PMID 31701693, PMID 33870484, PMID 34075142, PMID 37611246